MENU
donate

Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Lalita Shevde-Samant, PhD

The University of Alabama at Birmingham
Presented in memory of Heather Holmes
Altering the metastatic immune niche to eradicate established breast cancer metastases
Abstract Report
Summary Report

Yusuke Shiozawa, MD, PhD

Wake Forest University
An osteolytic bone lesion-targeted radiopharmaceutical for bone metastatic breast cancer
Abstract Report
Summary Report

Jawed Siddiqui, PhD

University of Nebraska Medical Center
Presented in memory of Heather Holmes
Therapeutic tareting of GFRAL/RET axis to overcome bone metastasis of breast cancer
Abstract Report
Summary Report

GINA SIZEMORE, PhD

Ohio State University
Targeting Novel Tumor-Stroma Interactions in Breast Cancer Brain Metastases
Abstract Report
Summary Report

Luis Solorio, PhD

Purdue University
Presented in honor of Susan Marr Williamson
Effect of Motion in the Metastatic Microenvironment
Abstract Report
Summary Report

Lou Song, PhD

University of Virginia
Oncogenic TRIM37 is a new driver of metastasis in triple negative breast cancer patients
Abstract Report
Summary Report

Khalid Sossey-Alaoui, PhD

Case Western Reserve University and MetroHealth Medical Center
Role of YB1 in Triple Negative Breast Cancer Metastasis
Abstract Report
Summary Report

DAVID SOTO-PANTOJA, PhD

Wake Forest School of Medicine Comprehensive Cancer Center
Anti-CD47 Immunotherapy as a Treatment for Metastatic Breast Cancer
Abstract Report
Summary Report

RACHEL STEWART, PhD

University of Kentucky
Characterizing Metastatic Breast Cancer Heterogeneity through Post-Mortem Tissue Collection
Abstract Report

Lijuan Sun, PhD

Cold Spring Harbor Laboratory
Presented In Memory of Rebecca McNally Gilden – Blessed mother, wife, daughter, engineer, friend and breast cancer advocate
Reprogramming innate-adaptive immune interactions to eliminate metastatic breast cancer
Abstract Report
Summary Report

WEI TAO, PhD

Harvard Medical School/Brigham and Women’s Hospital
Multi-staged delivery system overcoming the physiological barriers for metastatic breast cancer (MBC) therapy
Abstract Report

Paolo Tarantino, MD

Dana-Farber Cancer Institute
Presented by the #LightUpMBC Ambassador Team in Memory of Jessica Moore and all lives lost too soon to MBC
Identifying predictive biomarkers for novel antibody-drug conjugates
Abstract Report
donate

SHOP  |  BLOG  |  CALENDAR

Facebook-f Instagram X-twitter Youtube Linkedin-in